I am conducting an analysis on the uptake of biosimilar use for Ustekinumab.
I would be grateful if you could please tell me how many patients were treated with Ustekinumab (for any disease) for the three-month period specified within the questions.
Q1 – How many patients were treated with Ustekinumab and its biosimilars (for any disease) from the start of October 2024 to the end of December 2024?
Please use the latest available 3 months if October to December is not available and specify which 3 months have been used.
Q2 – How many patients were treated with Stelara and its biosimilars (for any disease) in the months October 2024, November 2024, and December 2024?
Please use the latest available 3 months if October to December is not available and specify which 3 months have been used.

